CALGB 90601 - A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab (IND #7921, NSC #704865) to Gemcitabine, Cisplatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma.

Clinical Trial Categories

• Bladder/Kidney Cancer (renal cancer)

Contact

The Rosenfeld Cancer Center at 215-481-2402